Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




How to Proceed after Abnormal Pap Results

By HospiMedica staff writers
Posted on 30 May 2002
New guidelines designed to help clinicians decide how to manage women whose Pap tests are abnormal were published in the April 24, 2002, issue of the Journal of the American Medical Association (JAMA).

The new guidelines describe how best to utilize new technologies, including liquid-based cytology and DNA testing for human papillomavirus (HPV), the primary cause of cervical cancer. More...
One of the most important recommendations addresses women with the most common type of abnormal Pap test, called ASCUS, or atypical squamous cells of undetermined significance. Prior to these guidelines, women with ASCUS would have either several repeat Pap tests or undergo a colposcopy. The new guidelines say other approaches may still be used, but HPV testing is preferred whenever liquid-based Pap tests are employed. If the liquid test is used, the laboratory can test the same sample used for the original Pap test for HPV, eliminating the need for a repeat doctor visit.

The test can reassure women who are HPV negative that they are unlikely to have cervical cancer, while identifying those women who are HPV positive and in need for further evaluation. For women with more serious abnormalities on their Pap test, the guidelines recommend colposcopy and find HPV testing has no role. This is an important change in recommended practice. The American Society for Colposcopy and Cervical Pathology (ASCCP) sponsored the guidelines, working with representatives from 29 national organizations and federal agencies involved in women's health care.

JAMA is making the Consensus Guidelines available at no charge on the Internet (www.ama-assn.org).




Related Links:
Consensus Guidelines

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.